Newtrend Group Holding Co., Ltd. 2025 Annual Report: Key Highlights and Investor Insights

Overview

Newtrend Group Holding Co., Ltd. (Stock Code: 2573), a leading manufacturer in the food additives sector, released its 2025 annual report following its listing on the Main Board of the Hong Kong Stock Exchange on June 10, 2025. The group specializes in the production and sale of food-grade glycine, industrial-grade glycine, and sucralose, with a growing focus on health-oriented and natural ingredient products.

Financial and Operational Highlights

• Revenue: The Group posted a revenue of RMB 583.2 million for 2025, a modest growth from RMB 568.9 million in 2024.
• Profitability: Profit before tax fell sharply to RMB 11.2 million (from RMB 48.7 million in 2024), with net profit at RMB 13.1 million (down from RMB 43.4 million). The main reasons include significantly increased administrative and finance costs.
• Gross Profit: Gross profit rose to RMB 108.6 million (2024: RMB 101.9 million), indicating improved cost controls at the gross level despite overall profit decline.
• Expenses:
  • Selling and marketing expenses surged 31.5% to RMB 6.3 million, mainly due to higher personnel and exhibition costs.
  • Administrative expenses jumped 59.2% to RMB 49.1 million, attributed to employee costs, intermediary fees, and depreciation.
  • Finance costs soared 270% to RMB 10.3 million, mainly due to increased borrowing interest.
  • R&D costs declined slightly by 5% to RMB 15.7 million.
• Income Tax: The Group recorded an income tax credit of RMB 1.8 million (2024: tax expense of RMB 5.3 million), reflecting the decline in profits.
• Cash Position and Liquidity: The Group reported bank deposits and cash totaling RMB 168.5 million, with a current ratio of 1.9 (2024: 1.2) and quick ratio of 1.6 (2024: 0.9), reflecting improved short-term liquidity.
• Gearing Ratio: The Group’s gearing ratio increased slightly to 70.8% (2024: 69.7%), indicating moderately higher leverage.

Corporate Actions & Significant Events

• IPO and Use of Proceeds: The company issued 10,585,400 new shares at HK\$18.90 each, raising net proceeds of HK\$164.15 million. As of year-end, only HK\$22.9 million had been utilized, with the majority slated for expansion projects in Thailand and new product lines (isomalt, seaweed dietary fiber, serine), R&D, and working capital by end-2026.
• Full Circulation of H Shares: In a major post-reporting event, 41,082,340 Domestic Shares were converted into H Shares, and the company’s H Share full circulation was completed in April 2026. The total issued shares reached 96,231,234, all now H Shares. This action significantly increases liquidity and potential market interest in the stock.
• Cash Management Note Controversy (Potentially Price Sensitive): The company invested HK\$65,000,000 (RMB 58.5 million) in a cash management note through a private Hong Kong entity. Notably, the payment for this note was made to a third-party “Designated Payee” rather than the issuer, and the auditor could not verify the legitimacy, business rationale, or underlying assets of the transaction. The auditor issued a qualified opinion due to insufficient audit evidence and was unable to confirm the classification, valuation, or related disclosures of this financial asset. This raises material uncertainties and potential risks regarding the recoverability and legitimacy of this significant investment, which could impact the company’s financial position and share value.

Business Outlook and Strategic Focus

• The Group is focused on tapping into growing health trends by developing products based on natural ingredients (e.g., curcumin, isomalt, seaweed fiber, rice starch/protein, resistant dextrin, crystalline maltitol, isomalto-oligosaccharide).
• The company expects to maintain growth momentum in its main segments (glycine, sweeteners) as downstream industries expand and global consumer demand for health products rises.
• Proceeds from the IPO will be used to fund new production lines, R&D enhancements, and working capital, with major capex planned for the Thailand plant and seaweed dietary fiber/serine production.

Risks and Shareholder Alerts

• Qualified Audit Opinion: The unresolved issues regarding the HK\$65 million cash management note and lack of audit evidence raise material concerns. This uncertainty could impact the company’s valuation and investor confidence, potentially affecting the share price.
• Concentration of Revenue: The top five customers accounted for 54.5% of total revenue, exposing the company to customer concentration risk.
• Increased Costs and Lower Profitability: Despite revenue growth, significant increases in certain cost categories (notably administrative and finance costs) led to a marked decline in net profits.
• No Dividend: The Board proposes not to declare a final dividend for 2025, which may disappoint income-focused investors.
• Major Investments: Other than the controversial cash management note, the company has not made or disposed of any major investments, acquisitions, or joint ventures.
• Regulatory and Trade Risk: As a major exporter, the company’s results are exposed to changes in international trade policies and barriers, particularly in Europe, North America, and Asia.
• Human Resource Risk: The company’s operations are heavily reliant on the continued service of key executives and managers.

Corporate Governance & Compliance

• The company has adopted the latest Corporate Governance Code and has implemented robust internal controls, anti-fraud, and compliance policies.
• No material non-compliance was reported during the year.
• The company maintains a minimum public float of 25% as required by the Listing Rules.

Conclusion

While Newtrend Group Holding reported steady revenue growth and maintains a robust cash position, the sharp decline in net profits, the controversial investment in the cash management note (leading to a qualified audit opinion), and the absence of a dividend warrant close attention from shareholders. The full circulation of H Shares and planned expansion into health-oriented products offer growth potential but come with execution and governance risks. The unresolved issues around the cash management note are particularly price-sensitive and could impact investor confidence and the company’s market valuation in the near term.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with professional advisers before making investment decisions. The information summarized herein is derived from the official annual report of Newtrend Group Holding Co., Ltd. and is believed to be accurate at the time of publication, but no liability is accepted for any errors or omissions.

View NEWTREND GROUP Historical chart here